Clinical Trials Directory

Trials / Completed

CompletedNCT02631408

Intrawound Vancomycin Powder in Spinal Fusion Surgery

Application of Intrawound Vancomycin Powder to Reduce Surgical Site Infections in Spinal Fusion Surgery - A Prospective, Randomized, Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
308 (actual)
Sponsor
Orthopedic Hospital Vienna Speising · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Vancomycin powder (for solution for Infusion) will be investigated (off-label usage) in spinal fusion surgery. The powder will be locally administered into to the wound cavity before wound closure. Hypothesis: Locally applied vancomycin powder leads to a reduction in postoperative surgical site infections

Detailed description

Vancomycin is being widely used as an antibiotic agent for intravenous and topical use. The surgical application of vancomycin powder in Austria is limited as there is no powder with marketing authorization for intraoperative, intrawound usage. Previous reports widely document the application of vancomycin powder for solution for infusion. The powder is not soluted, but instead directly spread throughout the wound surface. Limited data is available for spinal fusion surgery, mostly retrospective studies. Results were promising, but the low evidence level does not allow for a conclusion regarding routine usage. Additional randomized, controlled trials are necessary to further investigate this matter. This trial aims to investigate Vancomycin powder "Xellia" 1000mg, which has a Marketing authorization, in an off-label usage (intrawound, intraoperatively) in spinal fusion surgery. The investigational medicinal product will be used unmodified.

Conditions

Interventions

TypeNameDescription
DRUGVancomycinLocally, intrawound applied vancomycin powder

Timeline

Start date
2015-08-01
Primary completion
2019-03-01
Completion
2021-03-01
First posted
2015-12-16
Last updated
2021-03-03

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02631408. Inclusion in this directory is not an endorsement.